
Inebir and ANSEDH sign an agreement for patients with Ehlers-Danlos Syndrome
INEBIR and ANSEDH have signed a key agreement to improve genetic diagnosis and support for patients with Ehlers-Danlos Syndrome. This collaboration aims to offer priority access to advanced genetic testing, preferential conditions for ANSEDH members, and the promotion of new lines of biomedical research focused on rare diseases such as EDS.








